Evidence map›Paper›PMID 29734694›Full record

ArticleChildren (Basel, Switzerland)2018

Hearing Loss in Adult Survivors of Childhood Cancer Treated with Radiotherapy.

Amber Khan, Amy Budnick, Dana Barnea, Darren R Feldman, Kevin C Oeffinger, Emily S Tonorezos

Open access · goldAbstract read
In one paragraph

Article in Children (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Amber KhanSouthwestern Medical School, University of Texas, 5323 Harry Hines Blvd, Dallas, TX 75390, USA. ankhan92@gmail.com.
Amy BudnickMemorial Sloan Kettering Adult Long-Term Follow-Up Program, 485 Lexington Ave, 2nd Floor, New York, NY 10017, USA. budnicka@mskcc.org.
Dana BarneaTel Aviv Sourasky Medical Center, Survivorship Clinic, Hematology and Oncology, Weizmann St 6, Tel Aviv 64239, Israel. dana.barnea@gmail.com.
Darren R FeldmanMemorial Sloan Kettering Adult Long-Term Follow-Up Program, 485 Lexington Ave, 2nd Floor, New York, NY 10017, USA. Feldmand@mskcc.org.ORCID 0000-0003-2424-4635
Kevin C OeffingerDuke Cancer Institute, 2424 Erwin Drive, Suite 601, Durham, NC 27705, USA. kevin.oeffinger@duke.edu.
Emily S TonorezosMemorial Sloan Kettering Adult Long-Term Follow-Up Program, 485 Lexington Ave, 2nd Floor, New York, NY 10017, USA. tonoreze@mskcc.org.
Memorial Sloan Kettering Cancer Center · USDuke Cancer InstituteTel Aviv Sourasky Medical Center · ILThe University of Texas Southwestern Medical Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Summer research experiences for medical students supervised by faculty mentorsR25CA020449 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Charlotte Eielson Ariyan · 1985 to 2026
$6.2M
NCI NIH HHS P30 CA008748NCI NIH HHS R25 CA020449
6 · The paper itself

Abstract

The ototoxic effects of radiotherapy have been poorly characterized. We examined adult survivors of childhood cancer who were treated with radiotherapy, which included the head, before the age of 22 years and between 1952 and 2016. Those who received platinum chemotherapy were excluded. Demographic, diagnosis, and treatment outcomes were captured. Audiograms were graded using the Chang and International Society of Paediatric Oncology ototoxicity (SIOP) scales. Among 276 patients with a history of radiation to sites that included the brain, orbit, nasopharynx, and total body irradiation, the median age at treatment was 10.1 years and 59% were male. Of 51 survivors who had post-treatment audiograms, 19 demonstrated severe hearing impairment according to both the Chang and SIOP scales after a median follow-up of 16.6 years. Of those with severe impairment, 10 were using hearing aids. Among the 23 patients with more than one audiogram, five had normal hearing on the first audiogram but hearing loss upon subsequent study. Ototoxic effects of radiotherapy are present in a significant portion of survivors, but impairment may present over time, and our results suggest that many are not being screened. Further, among patients with severe hearing loss, use of hearing aids is not universal. Expansion of access to audiology testing and hearing interventions may be warranted.

Indexed as

hearing aidsototoxicitypediatric cancerradiotherapysurvivorship

Identifiers

PMID29734694
PMCPMC5977041
OpenAlexW2802471242

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.